跳至主要内容
临床试验/NCT02301052
NCT02301052Unknown1 期

Double Blind Randomized Placebo-control Trial of Allium Ampeloprasum Spp.Iranicum Cream Effect for the Management of Hemorrhoids Symptoms

Shiraz University of Medical Sciences1 个研究点 分布在 1 个国家目标入组 75 人开始时间: 2014年9月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
入组人数
75
试验地点
1
主要终点
pain (visual analogue scale(0-10))

研究概览

简要总结

Purpose of study is evaluation of Allium ampeloprasum Spp.Iranicum cream efficacy in management of symptomatic hemorrhoids in a double blind randomized placebo-control trial

详细描述

Purpose of study: evaluation of Allium ampeloprasum Spp.Iranicum cream efficacy for the management of hemorrhoids study design:Double blind randomized placebo-control trial, uni-central Study population: Participants having symptomatic hemorrhoids attending Shiraz University of Medical Sciences clinics Inclusion criteria: Patients with symptomatic hemorrhoids(GRADE 1-4) without need to emergency operation according to physical examination Exclusion criteria: Participants having anal fissure or inflammatory bowel disease or history of gastrointestinal cancer Sample size: 75 patients (tree groups) Interventions: Topical Allium ampeloprasum cream/ placebo cream/anti-hemorrhoid cream Time period: 3 week Outcome measures: pain,itching, bleeding, defecate discomfort, total improvement, constipation

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • Participants having anal fissure or inflammatory bowel disease or history of gastrointestinal cancer
  • Participants having hypersensitive predisposition or hypersensitive to Allium ampeloprasum or history of skin hypersensivity
  • Female participants under pregnancy or during breastfeeding period
  • Participants complicated by serious cardio cerebro vascular diseases, hepatic and renal diseases, diseases of hemopoietic system or neurologic disorders or ascitis g- history of steroid or anticoagulant drug consumption

研究组 & 干预措施

placebo

Placebo Comparator

placebo topical cream 2 cc twice daily for 3 weeks

干预措施: placebo topical cream (Drug)

Anti-hemorrhoid topical cream drug

Active Comparator

Anti hemorrhoid topical cream as a standard drug 2 cc twice daily for 3 week

干预措施: Anti-hemorrhoid topical cream (Drug)

Leek topical cream

Active Comparator

Leek (Allium Ampeloprasum Spp.Iranicum) topical cream 2 cc twice daily for 3 weeks

干预措施: Leek topical cream (Drug)

结局指标

主要结局

pain (visual analogue scale(0-10))

时间窗: 3 weeks

method of measurement: visual analogue scale(0-10)

bleeding ( questionnaire)

时间窗: 3 weeks

method of measurement questionnaire:grade (0-4) that was defined as follow: 0=no symptom, 1= mild, 2=moderate, 3= severe, 4=very severe.

itching ( questionnaire)

时间窗: 3 weeks

method of measurement questionnaire: grade (0-4) that was defined as follow: 0=no symptom, 1= mild, 2=moderate, 3= severe, 4=very severe.

defecate discomfort (visual analogue scale(0-10)

时间窗: 3 weeks

method of measurement: visual analogue scale(0-10)

total improvement (visual analogue scale(0-10)

时间窗: 3 weeks

method of measurement:visual analogue scale(0-10)

次要结局

  • constipation (questionnaire)(3 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Leyla Ghahramani

Shiraz university of medical sciences

Shiraz University of Medical Sciences

研究点 (1)

Loading locations...

相似试验